Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 16 Brain Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms by Site 2 Neoplasms 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor, Adult 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 1 1 Neuroblastoma 1 Multiple Myeloma 1 Medulloblastoma 1 Lung Neoplasms 1 Liposarcoma 1

Interventions

pembrolizumab 3 toripalimab 1 spartalizumab 1 sotorasib 1 pazopanib 1 palbociclib 1 abemaciclib 1 Trastuzumab 1 Therapeutics 1 Jupiter 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 Fulvestrant 1 EBI-005 1 Cetuximab 1 Catalytic Domain 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Tumor, Adult × abemaciclib × Clear all

NCT04092673 2024-05-21

Zotatifin

Effector Therapeutics

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡